Core Insights - Gilead Sciences has successfully added its new HIV prevention drug to CVS Health's commercial insurance plans, indicating a significant step in expanding access to the medication [1] Company Developments - The announcement was made by Gilead's CEO Daniel O'Day during a major industry conference, highlighting the company's commitment to addressing public health needs [1] Industry Impact - The inclusion of Gilead's drug in CVS Health's insurance plans may enhance the drug's market penetration and accessibility, potentially leading to increased sales and improved health outcomes for individuals at risk of HIV [1]